Broadcast

The Science of Radiofrequency Renal Denervation

Stefan Tunev, Andrew SP Sharp

Watch time: 1h 12m 55s

Broadcast

Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

Recent Advances in Pulmonary Hypertension

Published:

23 December 2024

Citation:

European Cardiology Review 2024;19:e25.

Resistant Hypertension: An Overview

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e07.

Link Between NAFLD/NASH and Cardiometabolic Syndrome

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e03.

Pre-eclampsia and CVD

Published:

07 June 2023

Citation:

European Cardiology Review 2023;18:e42.